Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Syneron Medical Ltd. (ELOS)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/01/2017
SC 13D/A
European High-Tech Capital S.A. reports a 0% stake in Syneron Medical Ltd.
07/27/2017
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]:
07/17/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017
25-NSE
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/17/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/07/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/15/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/30/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
05/18/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/15/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/11/2017
SC 13D/A
Sand Grove Capital Management LLP reports a 4.3% stake in SYNERON MEDICAL LTD
05/10/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/10/2017
SC 13D
Sand Grove Capital Management LLP reports a 5.2% stake in SYNERON MEDICAL LTD
05/01/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/19/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
04/10/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/03/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/03/2017
CT ORDER
Form CT ORDER - Confidential treatment order
03/27/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/23/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/23/2017
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/08/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/15/2017
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/14/2017
SC 13G/A
Visium Asset Management, LP reports a 0% stake in Syneron Medical Ltd.
02/14/2017
SC 13G/A
North Tide Capital Master, LP reports a 10.1% stake in SYNERON MEDICAL LTD.
02/13/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/07/2017
GN
Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors
02/07/2017
GN
Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors
01/10/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/06/2017
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy